MADISON, N.J., Nov. 10 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the
Credit Suisse Healthcare Conference on Wednesday, November 12, 2008. The
Quest Diagnostics presentation is scheduled to begin at 10:00 a.m. Eastern
Time.
During the conference, the company will reaffirm its 2008 guidance for
revenue growth of greater than 8%, operating income to approach 17% of
revenues, and adjusted earnings per diluted share from continuing operations
of between $3.17 and $3.22. This excludes the impact of a third quarter
equity investment write-down and hurricanes.
The presentation will be webcast live during the conference and will be
available to registered investors on the following site:
http://w.on24.com/r.htm?e=125462&s=1&k=FA4CC8E22828DA92BFF1D58C23AB47B1 and to
the public on www.QuestDiagnostics.com/investor. In addition, the archived
webcast will be available within 24 hours after the conclusion of the live
event and will remain available until December 14, 2008.
Quest Diagnostics is the world's leading provider of diagnostic testing,
information and services that patients and doctors need to make better
healthcare decisions. The company offers the broadest access to diagnostic
testing services through its national network of laboratories and patient
service centers, and provides interpretive consultation through its extensive
medical and scientific staff. Quest Diagnostics is a pioneer in developing
innovative new diagnostic tests and advanced healthcare information technology
solutions that help improve patient care. Additional company information is
available at: www.QuestDiagnostics.com.
SOURCE Quest Diagnostics
CONTACT: Investors, Laure Park, +1-973-520-2900; Media, Nancy
Fitzsimmons, +1-973-520-2800/
/Web Site: http://www.QuestDiagnostics.com /
(DGX)